DHL Expands Logistics Partnership with Sanofi in France

• DHL Supply Chain expands life sciences and healthcare logistics services in France through a strategic partnership with Sanofi.

• The partnership covers warehousing, inventory management, and order fulfillment at three key sites in France.

DHL Supply Chain has announced the expansion of its specialized logistics services for the life sciences and healthcare sector in France through a strategic partnership with Sanofi. This collaboration will involve warehousing, inventory management, picking and packing, and order fulfillment across three key sites: Amilly Distribution, Croissy-Beaubourg, and Saint-Loubès.

“This partnership strategically expands our existing, multi-country collaboration with Sanofi. By leveraging our combined global reach and scale and expertise in Healthcare in EMEA, we unlock significant synergies to optimize customer supply chains and create greater resilience,” said Hendrik Venter, regional CEO for DHL Supply Chain EMEA.

The new partnership aims to enhance the efficiency, resiliency, and standards of Sanofi’s logistics network. Ruth Beadle, head of global supply chain at Sanofi, stated, “We are delighted to partner with DHL to continue delivering the highest quality products in a sustainable way from France. We strongly believe that the Amilly, Croissy Beaubourg and Saint-Loubès distribution centers with its employees will continue to exercise same strive for excellence with DHL, through a new journey that will bring the most value to our customers and patients in France and all around the world.”

DHL Supply Chain will leverage its extensive resources, investments, and international network to support this partnership. The collaboration is reinforced by DHL’s experience across various segments, including pharmaceuticals, biopharmaceuticals, consumer health, vaccines, medical devices, clinical trials, hospitals, and healthcare establishments.

Nico Schütz, CEO DHL Supply Chain France, added, “Our dedicated team is highly trained and experienced in handling the specific requirements of life science products. We have the infrastructure, technology, and know-how to ensure quality assurance and rigorous compliance with French regulation.”